Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant and/or contract proposals applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant and/or contract proposals applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; NCI SPORE II Review.                    

*Date:*                         January 29-30, 2018.                    

*Time:*                         4:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.                    

*Contact Person:*                         Klaus B. Piontek, Ph.D., Scientific Review Officer,  Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W612, Bethesda, MD 20892-9750, 240-276-5413,                         *klaus.piontek@nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  Cancer Cachexia Therapy and Local Delivery of Chemopreventive Agents.                    

*Date:*                         February 8, 2018.                    

*Time:*                         9:00 a.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Jun Fang, Ph.D., Scientific Review Officer,  Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460,                         *jfang@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; TEP-6: Modified RNA and Oncosomes.                    

*Date:*                         February 14, 2018.                    

*Time:*                         9:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Jeffrey E. DeClue, Ph.D., Scientific Review Officer,  Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W114, Bethesda, MD 20892-9750, 240-276-6371,                         *decluej@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; NCI Program Project I.                    

*Date:*                         February 20-21, 2018.                    

*Time:*                         4:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878.                    

*Contact Person:*                         Klaus B. Piontek, Ph.D., Scientific Review Officer,  Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W612, Bethesda, MD 20892-9750, 240-276-5413.                         *klaus.piontek@nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Imaging Radiation and Immunotherapies.                    

*Date:*                         February 20-21, 2018.                    

*Time:*                         6:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Jun Fang, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460,                         *jfang@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Biological Comparisons in Patient-Derived Models of Cancer.                    

*Date:*                         February 23, 2018.                    

*Time:*                         1:00 p.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W236, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Robert S. Coyne, Ph.D., Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W236, Bethesda, MD 20892-9750, 240-276-5120,                         *coynes@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; TEP-2: Software Tools & Sensors for the Cancer Therapeutics.                    

*Date:*                         February 28-March 1, 2018.                    

*Time:*                         5:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Hilton Washington DC/Rockville Hotel,  1750 Rockville Pike, Bethesda, MD 20852.                    

*Contact Person:*                         Nadeem Khan, Ph.D.,  Scientific Review Officer,  Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-5856,                         *nadeem.khan@nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; SEP-1 for Provocative Questions.                    

*Date:*                         March 1, 2018.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878.                    

*Contact Person:*                         Byeong-Chel Lee, Ph.D.,  Scientific Review Officer,  Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609, Medical Center Drive, Room 7W238,  Bethesda, MD 20892-9750, 240-276-7755,                         *byeong-chel.lee@nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, NCI Clinical and Translational Exploratory/Developmental Studies.                    

*Date:*                         March 1-2, 2018.                    

*Time:*                         5:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Zhiqiang Zou, MD, Ph.D., Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W242, Bethesda, MD 20892-9750, 240-276-6372,                         *zouzhiq@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; NCI R03 & Clinical and Translational R21: SEP-1A.                    

*Date:*                         March 29, 2018.                    

*Time:*                         11:00 a.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W260, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Nadeem Khan, Ph.D.,  Scientific Review Officer,  Research Technology and Contract Review Branch, Division of Extramural Activities National, Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-5856,                         *nadeem.khan@nih.gov*.                    

                        (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399,                               ( print page 61310)                            Cancer Control, National Institutes of Health, HHS)                    

Dated: December 20, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2017-27939 Filed 12-26-17; 8:45 am]

 BILLING CODE 4140-01-P